Clayton Hutson – article recap

Clayton Hutson has done many great things during his career as a respected producer. He has led the industry in some of the most memorable shows and worked with some of the greatest artists. He has sat down to do an interview and has bestowed a little advice for everyone to follow. This advice is great for aspiring musicians and entrepreneurs alike. When asked what his best habits are as a producer he simply replied that he works three steps ahead of himself. He tries to stay ahead of the curve by focusing on what is coming next. When he wakes up he will plan out his entire day and delegate tasks as necessary. With his entire day planned out (even the menial tasks) he can clearly see what needs to be done, what is urgent, and what will take the most time. This level of efficiency has taken practice but it has served him well throughout his career. Learn more:


Clayton Hutson would offer the advice that everyone should always put family first. He would tell his younger self to always be completely honest with himself and others. By keeping family first and remaining honest in every possible situation he offers the chance for anyone to evolve into their best selves. He has an acute respect for human beings and believes that anyone can achieve their goals if they stick to their plan. The most talented people aren’t always the ones with the most positive outlook on life, they may sometimes be clumsy or socially unacceptable. As a manger he knows that the most positive people aren’t always the best at their jobs. He would rather employ someone who does the job with intense passion than someone who can’t keep up in the workplace. The most positive people do not matter to Clayton Hutson, what matter most is skill and expertise.


Clayton Hutson has been enthusiastic about music since he was a child and it shows in his work. He has developed his skills over the course of a lifetime and he will not stop getting better. Clayton Hutson is the very definition of what it means to be dedicated to perfection.


Scott Rocklage’s Role in Treating DM 1

Expansion Therapeutics is a company that is highly dedicated to the development of drugs that are used to treat RNA-mediated diseases. The group has been sponsored by a few companies in its quest to develop a drug for myotonic dystrophy type 1. These sponsor companies include Sanofi Ventures, Novartis Venture Fund, Kleiner Perkins, 5 AM Ventures, Alexandria Venture Investment, and RA Capital Management. The Managing Partner of 5 AM Ventures, Dr. Scott Rocklage is also the Chairman of the Board of Directors of Expansion Therapeutics. Learn more:


Myotonic dystrophy type 1 is also called DM 1. The disease is the leading cause of muscular dystrophy in adults. The signs and symptoms of the disease project themselves once RNA reaches toxic levels. RNAs are molecules that develop from DNA to form proteins. Production of some types of RNAs may reach toxic levels and lead to the formation of myotonic dystrophy type 1. When the disease is at its full-blown stage, body systems such as the gastrointestinal system, the respiratory system, and the central nervous system start to fail or slow down. Major organs such as the heart and muscles may begin to become defective and thus cause paralysis of other metabolic operations of the body.


Expansion Therapeutics mainly deals with the development of drugs for diseases that are called expansion repeat disorders. These are complications that are hereditary and have a slow response to the current medications on the market. The company conducts its developments in the laboratories of Dr. Matthew D. Disney. Dr. Scott Rocklage who is the founding investor of Expansion Therapeutics said in a press conference that the leading researcher in the drug development exercise is Dr. Disney.


Dr. Scott Rocklage has been the Managing Partner of 5 AM Ventures for many years. Dr. Rocklage is a graduate of some of the most reputable learning institutions in the country. He is a holder of Bachelor of Science degree in Chemistry from the University of California. He also has a Ph.D. in Chemistry from Massachusetts Institute of Technology (MIT). During his time at MIT, Mr. Scott Rocklage did his research in Dr. Richard Shrock’s laboratory. Dr. Shrock was the winner of the prestigious Nobel Prize in Chemistry in 2005.


He joined 5 AM Ventures in 2003 as a Venture Partner. In 2004, Dr. Rocklage was made the Managing Partner of the institution. He is highly experienced in the healthcare management. He was once the CEO of Cubist Pharmaceuticals. Dr. Rocklage was also the CEO and President of Nycomed Salutar at some point.